Tag: IDEXX Laboratories

  • Dignostice Substances: AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), Meridian Bioscience, Inc. (NASDAQ:VIVO), IDEXX Laboratories, Inc. (NASDAQ:IDXX), Palatin Technologies (NYSEMKT:PTN)

    AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced that William Heiden, AMAG’s chief executive officer, will present at the Cowen and Company 34 Annual Healthcare Conference on Monday, March 3, 2014 at 4:10 p.m. ET in Boston. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) stock opened at $21.11 in last session, and closed at $20.73, while the day range of stock is $20.42 – $21.28. The stock showed a negative weekly performance of -2.90%.

    Meridian Bioscience, Inc. (NASDAQ:VIVO) is an integrated life science company. The Company is engaged in developing, manufacturing, selling and distribution of clinical diagnostic test kits, for certain gastrointestinal, viral, respiratory and parasitic infectious diseases; the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/ quantitative polymerase chain reaction (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers, and the contract development and manufacture of proteins and other biologicals under cyclic guanosine monophosphate (cGMP) conditions for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines. Meridian Bioscience, Inc. (NASDAQ:VIVO) stock opened at $21.07, in last session and closed at $20.86, by losing -0.76%. The 52 week range of the stock is $19.15 – $27.72. Company’s market capitalization is $866.76 million.

    Trade-Ideas LLC identified IDEXX Laboratories, Inc. (NASDAQ:IDXX) as a new lifetime high candidate. IDEXX Laboratories, Inc. (NASDAQ:IDXX) stock decreased -0.36% and finished the last session at $125.90. The EPS of the stock remained 3.52. Company’s market capitalization is $6.50 billion.

    Palatin Technologies, Inc. (NYSEMKT:PTN) major shareholder Bvf Partners L. P/Il sold 540,181 shares of Palatin Technologies stock in a transaction dated Wednesday, February 26th. Palatin Technologies, Inc. (NYSEMKT:PTN) stock opened the session at $1.14, and closed the session at $1.06. The 52 week range of the stock remained $0.51 – $1.34 and the day range was $1.05 – $1.14.